Skip to main content
BLFS logo

BLFS · Biolife Solutions Inc

$31.15 +1.96 (+6.71%) At close · Jul 22
Market Cap
$1.52B
Shares
48.86M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2024
Executive Total
Roderick de Greef $7,046,205
Troy Wichterman $2,554,007
Aby J. Mathew $1,733,494
Karen Foster $1,515,139
Fiscal 2023
Executive Total
Roderick de Greef $5,316,798
Michael Rice $4,900,455
Troy Wichterman $1,697,221
Aby J. Mathew $1,345,688
Geraint Phillips $1,302,817
Karen Foster $1,122,877
Fiscal 2022
Executive Total
Michael Rice $4,729,170
Roderick de Greef $2,383,673
Troy Wichterman $1,754,856
Aby J. Mathew $1,699,294
Karen Foster $1,344,852
Geraint Phillips $840,054
Fiscal 2021
Executive Total
Michael Rice $2,249,907
Aby J. Mathew $1,218,360
Roderick de Greef $1,180,590
Marcus Schulz $1,053,670
Karen Foster $1,017,408
Troy Wichterman $570,564
Geraint Phillips $503,438
Fiscal 2020
Executive Total
Roderick de Greef $3,054,078
Michael Rice $1,478,511
Aby J. Mathew $1,056,363
Marcus Schulz $930,509
Karen Foster $887,078
Todd Berard $734,451
Troy Wichterman $587,309
Fiscal 2019
Executive Total
Michael Rice $2,241,770
Aby J. Mathew $1,222,816
Roderick de Greef $1,155,548
Karen Foster $920,073
Todd Berard $619,397
Marcus Schulz $345,079
Troy Wichterman $214,852
Fiscal 2018
Executive Total
Michael Rice $691,397
Aby J. Mathew $510,998
Roderick de Greef $489,998
Key facts CIK 834365 CUSIP 09062W204 13F (30d) 23 filings 20 filers Visit website